183 related articles for article (PubMed ID: 30203965)
1. Discovery of Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for Live-Cell and In Vivo Imaging.
Liu SY; Xiong H; Yang JQ; Yang SH; Li Y; Yang WC; Yang GF
ACS Sens; 2018 Oct; 3(10):2118-2128. PubMed ID: 30203965
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a butyrylcholinesterase-specific probe via a structure-based design strategy.
Yang SH; Sun Q; Xiong H; Liu SY; Moosavi B; Yang WC; Yang GF
Chem Commun (Camb); 2017 Apr; 53(28):3952-3955. PubMed ID: 28322391
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
Reid GA; Darvesh S
Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain.
Reid GA; Darvesh S
Curr Alzheimer Res; 2021; 18(6):470-481. PubMed ID: 34455970
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
Darvesh S
Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
[TBL] [Abstract][Full Text] [Related]
8. A turn-on fluorescent probe based on ESIPT and AIEE mechanisms for the detection of butyrylcholinesterase activity in living cells and in non-alcoholic fatty liver of zebrafish.
Pei X; Fang Y; Gu H; Zheng S; Bin X; Wang F; He M; Lu S; Chen X
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Feb; 287(Pt 1):122044. PubMed ID: 36327810
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
11. A novel near-infrared fluorescent probe for high-sensitivity detection of butyrylcholinesterase in various pathological states.
Jiang Y; Cui H; Yu Q
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Mar; 308():123801. PubMed ID: 38142494
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
13. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
14. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
15. Rational design of a near-infrared fluorescence probe for highly selective sensing butyrylcholinesterase (BChE) and its bioimaging applications in living cell.
Ma J; Lu X; Zhai H; Li Q; Qiao L; Guo Y
Talanta; 2020 Nov; 219():121278. PubMed ID: 32887168
[TBL] [Abstract][Full Text] [Related]
16. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
Greig NH; Utsuki T; Ingram DK; Wang Y; Pepeu G; Scali C; Yu QS; Mamczarz J; Holloway HW; Giordano T; Chen D; Furukawa K; Sambamurti K; Brossi A; Lahiri DK
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17213-8. PubMed ID: 16275899
[TBL] [Abstract][Full Text] [Related]
17. Thiol-ene click reaction-induced fluorescence enhancement by altering the radiative rate for assaying butyrylcholinesterase activity.
Chen G; Feng H; Xi W; Xu J; Pan S; Qian Z
Analyst; 2019 Jan; 144(2):559-566. PubMed ID: 30417195
[TBL] [Abstract][Full Text] [Related]
18. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
19. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.
Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):119-24. PubMed ID: 18486120
[TBL] [Abstract][Full Text] [Related]
20. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]